CAS: 1086062-66-9 - Omipalisib
Formula:C25H17F2N5O3S
InChI:InChI=1S/C25H17F2N5O3S/c1-35-25-23(32-36(33,34)24-5-3-18(26)12-21(24)27)11-17(13-29-25)15-2-4-22-20(10-15)19(7-8-28-22)16-6-9-30-31-14-16/h2-14,32H,1H3
InChI key:InChIKey=CGBJSGAELGCMKE-UHFFFAOYSA-N
SMILES:O=S(=O)(NC=1C=C(C=NC1OC)C=2C=CC3=NC=CC(C=4C=NN=CC4)=C3C2)C5=CC=C(F)C=C5F
- Synonyms:
- 2,4-Difluoro-N-[2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]benzenesulfonamide
- Benzenesulfonamide, 2,4-difluoro-N-[2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]-
- Gsk 2126458
- Gsk 458
- Gsk2126458
GSK-2126458
CAS:1086062-66-9
Formula:
C25H17F2N5O3S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
505.4960
Ref: AN-AG008TGQ
2mg | 107.00 € | |
5mg | 159.00 € | |
10mg | 200.00 € | |
25mg | 618.00 € | |
50mg | To inquire |
Estimated delivery in United States, on Thursday 16 May 2024
Ref: 7W-GW9665
1mg | 371.00 € | |
5mg | 548.00 € | |
10mg | 819.00 € |
Estimated delivery in United States, on Thursday 23 May 2024
Omipalisib
CAS:1086062-66-9
Omipalisib (GSK2126458) is a small-molecule pyridylsulfonamide inhibitor of phosphatidylinositol 3-kinase (PI3K) with potential antineoplastic activity.
Formula:
C25H17F2N5O3S
Purity:
99.8%
Color and Shape:
Solid
Molecular weight:
505.5
- Inhibitors
- Autophagy
- PI3K/Akt/mTOR Signaling
- PI3K
- See more categories
- mTOR
Ref: TM-T1861
5mg | 62.00 € | |
10mg | 94.00 € | |
25mg | 172.00 € | |
50mg | 272.00 € | |
100mg | 417.00 € | |
1ml*10 (DMSO) | 68.00 € |
Estimated delivery in United States, on Thursday 23 May 2024
GSK 2126458
Controlled ProductCAS:1086062-66-9
Formula:
C25H17F2N5O3S
Color and Shape:
White to Pale Yellow Solid
Molecular weight:
505.5
Ref: TR-G797500
1mg | 116.00 € | |
10mg | 206.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
GSK 2126458
CAS:1086062-66-9
PI3K enzyme inhibitor; antineoplastic
Purity:
Min. 98 Area-%
Color and Shape:
Powder
Ref: 3D-FD43337
5mg | 74.00 € | |
10mg | 120.00 € | |
25mg | 243.00 € | |
50mg | 406.00 € | |
100mg | 632.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024